Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Daiken Medical CoTSE:7775 +0.24%62 FCF Margin % is 3.28% as of Mar. 2026, which is 62% below its 10-year median of 8.72. GuruFocus rates TSE:7775 with a GF Score™ of 62/100 and a GF Value™ of 円541.84 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Daiken Medical Co ranks better than 56.07% on this metric.
The historical rank and industry rank for Daiken Medical Co's FCF Margin % or its related term are showing as below:
TSE:7775'
s FCF Margin % Range Over the Past 10 Years
Min: 2.33 Med: 8.72 Max: 14.87
Current: 2.33
During the past 13 years, the highest FCF Margin % of Daiken Medical Co was 14.87%. The lowest was 2.33%. And the median was 8.72%.
TSE:7775's FCF Margin % is ranked better than 56.07% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.56
vs TSE:7775: 2.33
Daiken Medical Co FCF Margin % Related Terms
Daiken Medical Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for Daiken Medical Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7775 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Daiken Medical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daiken Medical Co FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Daiken Medical Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Daiken Medical Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daiken Medical Co (TSE:7775) has a FCF Margin % of 3.28% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Daiken Medical Co and its competitors. This is 62% below median its historical median of 8.72. Over the past decade, Daiken Medical Co's FCF Margin % has ranged from 2.33 to 14.87. According to the industry distribution chart, Daiken Medical Co ranks #358 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 43.9%.
Is Daiken Medical Co's FCF Margin % too high?
Daiken Medical Co's current FCF Margin % of 3.28% is 62% below median its 10-year median of 8.72. Over the past 10 years, this metric has ranged from a low of 2.33 to a high of 14.87. Based on the distribution chart, Daiken Medical Co ranks #358 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Daiken Medical Co has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiken Medical Co's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Daiken Medical Co ranks #358 out of 815 companies for FCF Margin %. This puts Daiken Medical Co in the upper half of its industry. Historically, Daiken Medical Co's own FCF Margin % has ranged from 2.33 to 14.87 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Daiken Medical Co and its competitors. Daiken Medical Co's current FCF Margin % is 3.28%, which is 62% below median its own 10-year median of 8.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Daiken Medical Co (TSE:7775) is currently considered Modestly Undervalued. The stock's GF Value™ is 円541.84, compared to a current price of 円426.00 — trading 21.4% below its estimated fair value. The current FCF Margin % is 3.28%, which is 62% below median its 10-year median of 8.72. Daiken Medical Co's overall GF Score™ is 62/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Daiken Medical Co (TSE:7775), the current FCF Margin % is 3.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daiken Medical Co (TSE:7775) Overvalued in 2026?
Based on GuruFocus' analysis, Daiken Medical Co stock appears to be undervalued.
The current stock price of 円426.00 is trading 21.4% below its estimated GF Value™ of 円541.84.
GuruFocus considers Daiken Medical Co to be Modestly Undervalued.
Key valuation signals for TSE:7775:
FCF Margin %: 3.28% (62% below median its 10-year median of 8.72)
GF Value™: 円541.84 vs. price of 円426.00 (21.4% below fair value)
No single metric tells the full story. See the TSE:7775 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daiken Medical Co Ltd manufactures and sells medical equipment. The product line includes - Coopdech syrinjector, Coopdech Syrinjector PCA device, Coopdech Balloonjector, Coopdech Endobronchial blocker tube, Coopdech double-lumen endobronchial tube, Fit fix suction container system, Wet disinfectant mat, and others.
62GF Score
Get the complete analysis for TSE:7775
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7775 has been successfully added to your 
